Effect of Progesterone on Latent Phase Prolongation in Patients With Preterm Premature Rupture of Membranes
Status:
Completed
Trial end date:
2020-12-10
Target enrollment:
Participant gender:
Summary
The aim of the study is to assess the efficacy of 17-hydroxyprogesterone caproate (17P)
therapy on the latency period in pregnant women with Preterm premature rupture of membranes.